Search research articles
Contact Us
Filters
Showing results (101-110 of 123) with videos related to
Page
of 13
Sort By:
Cancer Medicine
|
September 24, 2020
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study
Antonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Blood Advances
|
October 13, 2021
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
Carlo Visco, Luigi Marcheselli, Roberto Mina, et al.
Frontiers in Immunology
|
March 13, 2023
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, et al.
International Journal of Antimicrobial Agents
|
August 15, 2023
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, et al.
Leukemia & Lymphoma
|
November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
The Lancet. Haematology
|
August 18, 2020
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 123) with videos related to
Sort By:
Page
of 13
Cancer Medicine
|
September 24, 2020
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study
Antonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Therapeutic Advances in Hematology
|
March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Monia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Blood Advances
|
October 13, 2021
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
Carlo Visco, Luigi Marcheselli, Roberto Mina, et al.
Frontiers in Immunology
|
March 13, 2023
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, et al.
International Journal of Antimicrobial Agents
|
August 15, 2023
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, et al.
Leukemia & Lymphoma
|
November 15, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Shaimaa El-Ashwah, Jon Salmanton-García, Yavuz M Bilgin, et al.
The Lancet. Haematology
|
August 18, 2020
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Page
of 13